Cargando…
MiR-27a as a diagnostic biomarker and potential therapeutic target in systemic sclerosis
Systemic sclerosis (SSc) or scleroderma is a multiorgan rheumatoid disease characterized by skin tightening or organ dysfunction due to fibrosis, vascular damage, and autoimmunity. No specific cause has been discovered for this illness, and hence no effective treatment exists for it. On the other ha...
Autores principales: | Bayati, Paria, Kalantari, Mahsa, Assarehzadegan, Mohammad-Ali, Poormoghim, Hadi, Mojtabavi, Nazanin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640682/ https://www.ncbi.nlm.nih.gov/pubmed/36344812 http://dx.doi.org/10.1038/s41598-022-23723-7 |
Ejemplares similares
-
Aberrant expression of miR-138 as a novel diagnostic biomarker in systemic sclerosis
por: Bayati, Paria, et al.
Publicado: (2022) -
Circulating CTRP5 in rheumatoid arthritis: an exploratory biomarker study
por: Taherian, Marjan, et al.
Publicado: (2022) -
Progesterone Aggravates Lung Fibrosis in a Mouse Model of Systemic Sclerosis
por: Vafashoar, Fatemeh, et al.
Publicado: (2021) -
Induced pluripotent stem cells modulate the Wnt pathway in the bleomycin-induced model of idiopathic pulmonary fibrosis
por: Bayati, Paria, et al.
Publicado: (2023) -
C1q/TNF-related protein-1: Potential biomarker for early diagnosis of autism spectrum disorder
por: Raeisy, Hamed, et al.
Publicado: (2022)